Cargando…
Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies for apolipoprotein-AII isoforms
We recently reported that circulating apolipoprotein AII (apoAII) isoforms apoAII-ATQ/AT (C-terminal truncations of the apoAII homo-dimer) decline significantly in pancreatic cancer and thus might serve as plasma biomarkers for the early detection of this disease. We report here the development of n...
Autores principales: | Honda, Kazufumi, Kobayashi, Michimoto, Okusaka, Takuji, Rinaudo, Jo Ann, Huang, Ying, Marsh, Tracey, Sanada, Mitsuaki, Sasajima, Yoshiyuki, Nakamori, Shoji, Shimahara, Masashi, Ueno, Takaaki, Tsuchida, Akihiko, Sata, Naohiro, Ioka, Tatsuya, Yasunami, Yohichi, Kosuge, Tomoo, Miura, Nami, Kamita, Masahiro, Sakamoto, Takako, Shoji, Hirokazu, Jung, Giman, Srivastava, Sudhir, Yamada, Tesshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637825/ https://www.ncbi.nlm.nih.gov/pubmed/26549697 http://dx.doi.org/10.1038/srep15921 |
Ejemplares similares
-
Altered Plasma Apolipoprotein Modifications in Patients with Pancreatic Cancer: Protein Characterization and Multi-Institutional Validation
por: Honda, Kazufumi, et al.
Publicado: (2012) -
Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics
por: Yoneyama, Toshihiro, et al.
Publicado: (2016) -
Carbonic Anhydrase I as a New Plasma Biomarker for Prostate Cancer
por: Takakura, Michiko, et al.
Publicado: (2012) -
Biomarker Discovery of Pancreatic and Gastrointestinal Cancer by 2DICAL: 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry
por: Ono, Masaya, et al.
Publicado: (2012) -
Association of Pancreatic Fatty Infiltration With Pancreatic Ductal Adenocarcinoma
por: Hori, Mika, et al.
Publicado: (2014)